New research reveals that GLP-1 receptor agonists significantly lower mortality risk in older cancer patients with type 2 ...

People with obesity who take weight loss and diabetes drugs like Ozempic and Mounjaro could face a lower risk of cancer compared to those with obesity who do not. Looking at 14 cancers, of which 13 ...

New peptide drugs could take aim at a broader range of proteins that cause certain cancers, viral infections, and brain ...

After years of struggling with postpartum weight gain despite strict training and healthy eating, the 23-time Grand Slam ...

As cancer progression has been linked with high glucose, adiposity, insulin resistance, and systemic inflammation, investigators studied several glucose-lowering drugs in relationship to cancer ...

A new imaging approach reveals how dual agonist drugs like tirzepatide act on the pancreas and brain to regulate blood sugar and appetite.

GLP-1 drugs like Ozempic and Wegovy have surged in popularity for weight loss, but their high cost and side effects fuel interest in supplements. Backed by celebrities like Kourtney Kardashian, these ...

If you have hypoglycemia during Ozempic treatment, it’s possible that once your blood sugar is stable, the blurred vision will clear. If it doesn’t clear or you have any other vision problems that ...

Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

Discover a study exploring how GLP-1 receptor agonists may reduce symptoms of hidradenitis suppurativa through weight loss and anti-inflammatory effects.

Whole grains high in soluble fiber can actually help improve insulin resistance. Oats, barley, buckwheat, brown rice and ...